IntelliCyt Corp.

Screening Solutions for Life

  • applications
  • HTFC
  • HyperCyt Sampler
  • HyperCytPRO

IntelliCyt® Biologics Discovery program takes aim on antibody screening

The  HTFC Screening System and our “mix-and-measure” intact cell assay for primary screening simultaneously assesses antigen binding and cross-reactivity with higher throughput, greater sensitivity and dynamic range.

  • measures cells in suspension, so epitopes can be measured in their native state
  • reduces workflow steps and increases productivity
  • reads a 384-well plate in under 15 minutes.

IntelliCyt customers report up to a 24X increase in throughput, dramatically increasing their opportunity for success in discovering antibodies to treat cancer, cardiovascular disease, diabetes, autoimmune diseases or AIDS. More Information»

Announcing a free tutorial at SLAS2012, Feb. 7th, 12:30-2:00PM at the San Diego Convention Center, Room 16A

"Increasing the Power and Scope of Phenotypic Screening with the IntelliCyt HTFC® Screening System"

Sign up»